162 related items for PubMed ID: 11410120
21. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J.
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[Abstract] [Full Text] [Related]
22. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[Abstract] [Full Text] [Related]
23. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Hemelaar M, Kenemans P, Hack CE, Klipping C, van der Mooren MJ.
Menopause; 2008 Jul; 15(2):248-55. PubMed ID: 17693902
[Abstract] [Full Text] [Related]
24. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP.
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
[Abstract] [Full Text] [Related]
25. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T, Khan MM, Colman RW, Edmunds LH.
J Am Coll Cardiol; 2005 Aug 16; 46(4):707-13. PubMed ID: 16098440
[Abstract] [Full Text] [Related]
26. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
Bröijersén A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, Angelin B, Hjemdahl P.
Thromb Haemost; 1996 Aug 16; 76(2):171-6. PubMed ID: 8865525
[Abstract] [Full Text] [Related]
27. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
Kwok S, Charlton-Menys V, Pemberton P, McElduff P, Durrington PN.
Maturitas; 2006 Mar 20; 53(4):439-46. PubMed ID: 16139447
[Abstract] [Full Text] [Related]
28. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS, Christella M, Thomassen LG, van der Mooren MJ, van Baal WM, Rosing J, Kenemans P, Stehouwer CD.
Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):1116-21. PubMed ID: 12730085
[Abstract] [Full Text] [Related]
29. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J, Hammar M.
Maturitas; 2005 Apr 11; 50(4):344-52. PubMed ID: 15780536
[Abstract] [Full Text] [Related]
30. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC, WHISP (Women's Hormone Intervention Secondary Prevention Study) Pilot Study Investigators.
Eur Heart J; 2006 Sep 11; 27(17):2046-53. PubMed ID: 16899475
[Abstract] [Full Text] [Related]
31. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE, Teede HJ, Malan E, Kotsopoulos D, Smolich JJ, McGrath BP.
Clin Sci (Lond); 2007 Nov 11; 113(9):383-91. PubMed ID: 17608627
[Abstract] [Full Text] [Related]
32. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA.
Thromb Haemost; 2000 Jul 11; 84(1):124-8. PubMed ID: 10928482
[Abstract] [Full Text] [Related]
33. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy.
Laine K, Palovaara S, Tapanainen P, Manninen P.
Clin Pharmacol Ther; 1999 Dec 11; 66(6):602-8. PubMed ID: 10613616
[Abstract] [Full Text] [Related]
34. The efficacy of dietary intervention alone or combined with hormone replacement therapy in postmenopausal women with hypercholesterolemia in Seoul, Korea.
Jung K, Kim S, Woo J, Chang Y.
Eur J Nutr; 2002 Jun 11; 41(3):101-7. PubMed ID: 12111046
[Abstract] [Full Text] [Related]
35. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.
Leurs PB, van Oerle R, Wolffenbuttel BH, Hamulyak K.
Thromb Haemost; 1997 Mar 11; 77(3):472-6. PubMed ID: 9065996
[Abstract] [Full Text] [Related]
36. Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
Rousseau A, Robert A, Gerotziafas G, Torchin D, Zannad F, Lacut K, Libersa C, Dasque E, Démolis JL, Elalamy I, Simon T.
Fundam Clin Pharmacol; 2010 Apr 11; 24(2):239-45. PubMed ID: 19719551
[Abstract] [Full Text] [Related]
37. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG.
Am J Hematol; 1999 Mar 11; 60(3):175-80. PubMed ID: 10072106
[Abstract] [Full Text] [Related]
38. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
Neven P, Lunde T, Benedetti-Panici P, Tiitinen A, Marinescu B, de Villiers T, Hillard T, Cano A, Peer E, Quail D, Nickelsen T, Eurolox 1 Study Group.
BJOG; 2003 Feb 11; 110(2):157-67. PubMed ID: 12618160
[Abstract] [Full Text] [Related]
39. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G, Ozmen B, Erguder I.
Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
[Abstract] [Full Text] [Related]
40. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
Lean SY, Ellery P, Ivey L, Thom J, Oostryck R, Leahy M, Baker R, Adams M.
Haematologica; 2006 Oct 10; 91(10):1360-6. PubMed ID: 17018385
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
